Philips to distribute Corindus robotic-assisted PCI system

| | Health Exec | Artificial Intelligence
Robotics - 164.83 Kb
Corindus Vascular Robotics receives FDA 510(k) clearance for the CorPath 200 System to assist interventional cardiologists in performing PCI. Source: Corindus Vascular Robotics
Royal Philips Electronics and Corindus Vascular Robotics have signed a U.S. distribution agreement for Corindus’ CorPath 200 system, the recently FDA-approved robotic-assisted system to be used during PCI procedures.

The financial details of the exclusive distribution agreement were not disclosed. Philips owns a minority share in the Natick, Mass.-based Corindus, which commercializes robotic-assisted systems for interventional cardiology procedures.

The CorPath 200 system can be integrated with x-ray fluoroscopy systems including Philips’ Allura x-ray equipment. The robotic-assisted system can be used with standard stents, catheters and guidewires, the companies said in a press release. The CorPath 200 system is operated by the interventional cardiologist from a radiation shielded, interventional cockpit.

The distribution agreement enables both companies to sell the robotic-assisted system in the U.S.

Related Content

5 benefits of AI-enabled EHR systems
FDA regulator examines AI's growing influence in cardiology
AI in the ICU (and elsewhere): Less stress, better conditions, alleviated shortages
4 ways HHS plans to help shape a national strategy for healthcare AI
FDA has now cleared more than 1,000 AI models, including many in cardiology
Forging ahead with enterprise AI? Don’t wait to bring in your cybersecurity people

Around the web

Cardiovascular Business
Biden chooses semaglutide for next round of Medicare price negotiations—Trump gets final say

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

AI in Healthcare
4 ways HHS plans to help shape a national strategy for healthcare AI

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.

Cardiovascular Business
FDA announces recall after Philips heart monitor software failed to send alerts—multiple deaths reported

Philips is recalling the software associated with its Mobile Cardiac Outpatient Telemetry devices after certain high-risk ECG events were never routed to trained cardiology technicians as intended. The issue, which lasted for two years, has been linked to more than 100 injuries.